Sellers, Thomas A.
LLC,
United States
2025 Rank: 37234
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 95 out of 9991 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37234 | 38099 |
| Total Cites | 29163 | 34632 |
| H-index | 92 | 98 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 35 | 37 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 1798 | 2009 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 7054 | 7940 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24049 | 26481 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.31 |
| Self-Citation Percentage |
15.79%
|
|
Sellers, Thomas A.
LLC,
United States
2024 Rank: 35924
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 95 out of 9875 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35924 | 36198 |
| Total Cites | 27795 | 33063 |
| H-index | 89 | 97 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 33 | 35 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 1750 | 1963 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 6720 | 7603 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 22917 | 25254 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.31 |
| Self-Citation Percentage |
15.93%
|
|
Sellers, Thomas A.
Oregon Health & Science University,
United States
2023 Rank: 34184
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 96 out of 9487 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34184 | 34507 |
| Total Cites | 26433 | 31461 |
| H-index | 88 | 95 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 31 | 33 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 1720 | 1933 |
| Number of Single+First+Last Authored Papers | 115 | 115 |
| Total Cites to Single+First+Last Authored Papers | 6377 | 7254 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21780 | 23987 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.31 |
| Self-Citation Percentage |
15.98%
|
|
Sellers, Thomas A.
FL,
United States
2022 Rank: 33818
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 102 out of 9365 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33818 | 33664 |
| Total Cites | 24087 | 28496 |
| H-index | 82 | 90 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 30 | 32 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1660 | 1873 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 5974 | 6848 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19930 | 21927 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.30 |
| Self-Citation Percentage |
15.47%
|
|
Sellers, Thomas A.
Moffitt Cancer Center,
United States
2021 Rank: 32934
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 110 out of 9307 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32934 | 32155 |
| Total Cites | 23305 | 27596 |
| H-index | 81 | 89 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 30 | 32 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1615 | 1827 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 5735 | 6596 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19277 | 21216 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.30 |
| Self-Citation Percentage |
15.55%
|
|
Sellers, Thomas A.
Moffitt Cancer Center,
United States
2020 Rank: 29982
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 1436 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29982 | 29918 |
| Total Cites | 22074 | 26293 |
| H-index | 78 | 86 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 30 | 32 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1587 | 1798 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 5334 | 6187 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18154 | 20010 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.31 |
| Self-Citation Percentage |
16.05%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.